Description

Sodium(R)-2-(5-(2-(3-Ethylureido)-6-Fluoro-7-(Tetrahydrofuran-2-Yl)-1H-Benzo[D]Imidazol-5-Yl)Pyrimidin-2-Yl)Propan-2-Ylphosphate is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the research and development of targeted therapeutic agents, particularly in oncology and antiviral drug discovery pipelines. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the synthesis of novel active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel small-molecule drug candidates, especially kinase inhibitors.
• Oncology Research: Used in the development of targeted cancer therapies due to its specific molecular scaffold.
• Antiviral Drug Development: Serves as a precursor in the research of antiviral compounds.
• Biochemical Research: Utilized as a reference standard or probe in biochemical and pharmacological studies to understand enzyme interactions.
• Preclinical Development: Supplied for use in formulation studies and preclinical testing of new chemical entities (NCEs).
• Custom Synthesis: Starting material for contract manufacturing organizations (CMOs) specializing in complex, multi-step organic synthesis.

Basic Information

Product Name	Sodium(R)-2-(5-(2-(3-Ethylureido)-6-Fluoro-7-(Tetrahydrofuran-2-Yl)-1H-Benzo[D]Imidazol-5-Yl)Pyrimidin-2-Yl)Propan-2-Ylphosphate
CAS No.	1384984-31-9
Molecular Formula	C25H30FN6NaO6P
Molecular Weight	598.51 g/mol
Synonyms	Sodium (R)-2-[5-[2-(3-Ethylureido)-6-fluoro-7-(oxolan-2-yl)-1H-benzimidazol-5-yl]pyrimidin-2-yl]propan-2-yl phosphate; (R)-2-(5-(2-(3-Ethylureido)-6-Fluoro-7-(Tetrahydrofuran-2-yl)-1H-Benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl Phosphate Sodium Salt; 1384984-31-9; UNII-6V8G8P8V4S; 6V8G8P8V4S; Sodium 2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl hydrogen phosphate
EINECS	Contact for details

Quality Control

Our Sodium(R)-2-(5-(2-(3-Ethylureido)-6-Fluoro-7-(Tetrahydrofuran-2-Yl)-1H-Benzo[D]Imidazol-5-Yl)Pyrimidin-2-Yl)Propan-2-Ylphosphate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing including HPLC for purity and identity confirmation, residual solvent analysis, and chiral purity verification to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting compliance with agreed specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under inert atmosphere or in a desiccated environment after opening to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	< 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.